ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00531	Glycosaminoglycan degradation	3/34	23/7206	0.000159369803848
ko00983	Drug metabolism - other enzymes	3/34	42/7206	0.000971707922621
ko00600	Sphingolipid metabolism	3/34	63/7206	0.00314180694223
ko00944	Flavone and flavonol biosynthesis	1/34	1/7206	0.00471829031363
ko00040	Pentose and glucuronate interconversions	2/34	26/7206	0.00654232817628
ko00511	Other glycan degradation	2/34	26/7206	0.00654232817628
ko00254	Aflatoxin biosynthesis	1/34	2/7206	0.00941497013742
ko00052	Galactose metabolism	2/34	33/7206	0.0104119799937
ko00860	Porphyrin and chlorophyll metabolism	2/34	34/7206	0.0110302457663
ko00982	Drug metabolism - cytochrome P450	2/34	37/7206	0.012979784905
ko05215	Prostate cancer	3/34	111/7206	0.0150492748807
ko00980	Metabolism of xenobiotics by cytochrome P450	2/34	40/7206	0.0150682237816
ko04623	Cytosolic DNA-sensing pathway	2/34	41/7206	0.0157945321858
ko04668	TNF signaling pathway	3/34	120/7206	0.0185146605072
ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1/34	4/7206	0.0187438818745
ko00260	Glycine, serine and threonine metabolism	2/34	48/7206	0.021285821317
ko05204	Chemical carcinogenesis	2/34	48/7206	0.021285821317
ko04931	Insulin resistance	3/34	137/7206	0.0261812627915
ko04142	Lysosome	3/34	151/7206	0.0335996471057
ko04622	RIG-I-like receptor signaling pathway	2/34	62/7206	0.0342534043853
ko00561	Glycerolipid metabolism	2/34	63/7206	0.0352734567605
ko00950	Isoquinoline alkaloid biosynthesis	1/34	10/7206	0.0462218639563
ko01524	Platinum drug resistance	2/34	76/7206	0.0495634159902
ko05206	MicroRNAs in cancer	3/34	177/7206	0.0499845137747